|
|
|
New hope for newborns affected by rare lung disease
March 21,
2025
-
A team led by Drs. Bernard Thébaud, Sarah Wootton and Martin Kang found a way to give multiple doses of gene therapy for a deadly newborn lung disease, dramatically extending the lives of mice with this condition.
|
|
|
|
|
|
Synthetic biology startup raises US$ 2M
March 14,
2025
-
Esphera SynBio, a startup company founded by researchers at The Ottawa Hospital/University of Ottawa and McMaster University, has secured US$ 2 million in seed funding to support the development of personalized cancer vaccines.
|
|
|
|
|
|
‘Rising star’ explains his path from a broken bone arm wrestling to mental health discovery
March 13,
2025
-
Emerging researcher and psychiatry resident Dr. Nicholas Fabiano was profiled as a “rising star” in the new journal Brain Medicine.
|
|
|
|
|
|
Blood thinners can prevent vein blood clots in those with cancer, but results for artery clots are mixed
March 13,
2025
-
“Blood thinners are an effective tool for preventing vein blood clots in people with cancer. The fact they may also prevent artery clots in eligible patients with pancreatic cancer should encourage their use in that population."
|
|
|
|
|
|
Mouse study further supports role of muscle stem cells in Duchenne muscular dystrophy
March 13,
2025
-
“This study confirms that we’ll need to target both muscle fibres and muscle stem cells in order to treat this disease."
|
|
|
|
See all news items | See only press releases | Search for news and experts by disease / specialty
|
|
|
Media contacts
Jennifer Ganton
Director, Communications and Public Relations,
613-614-5253
jganton@ohri.ca
|
